MOTS-c in an Experimental Gestational-Diabetes Model
This study measured circulating MOTS-c in a human gestational-diabetes cohort and tested MOTS-c in an experimental mouse model.
Study design
Researchers compared circulating levels between clinical groups and assessed glucose-related outcomes, insulin resistance and signalling pathways after MOTS-c exposure in gestational-diabetes-model mice.
What the researchers reported
The paper reported altered circulating MOTS-c in the clinical comparison and improvements in glucose and insulin-related measurements in the treated mouse model, with AMPK-related signalling implicated.
What this result does not establish
The human data were associative, while intervention data came from mice. The study does not establish efficacy or safety for gestational diabetes in humans.
This article summarizes one published study about MOTS-c. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.
Related research material
Review the corresponding catalogue listing, labelled amount and available documentation. The study may use a different formulation or experimental preparation; it does not verify our product, its batch or suitability for human use.
Our Approach
Evidence before assumption.
TAM Global Research focuses on transparent documentation, careful scientific interpretation and clear distinction between what available evidence supports and what requires further verification.
Explore our quality standards